Pediatric hematologist-oncologist explores the complex relationship between cancer treatment’s toxicities and reduced nutritional intake.
Radium Knocks Out Tumor Cells in Case of Unresectable Paraspinal Osteosarcoma
A treatment-resistant paraspinal mass in a 24-year-old patient was affecting his ability to walk. Its location made local control nearly impossible. A novel agent and committed care team were able to change course and shrink the tumor with radium-223, an alpha emitting therapeutic.
ONC201 and Neuroendocrine Tumors: Promising Findings From a Phase II Trial
The small molecule ONC201 has shown promise as an effective, well-tolerated drug in the treatment of neuroendocrine tumors (NETs), report the authors of a Cleveland Clinic-led study.
Treating a Rare Ewing Sarcoma Case With Patience and Persistence
When a 4-year-old patient was diagnosed with a rare type of Ewing sarcoma, her team of pediatric and surgical oncologists came together with a plan that deviated slightly from the traditional treatment paradigm. This approach, her physicians say, allowed them to salvage significant anatomy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New Drug Holds Promise for Rare Neuroendocrine Tumors
A new study led by Cleveland Clinic researchers suggests that the small molecule ONC201 has promise as a less toxic treatment for pheohromocytomas/paragangliomas, and possibly other rare neuroendocrine tumors as well.
New Study Demonstrates Effectiveness of Cytoreductive Surgery for Desmoplastic Small Round Cell Tumor
Results of a Phase 2 trial offer much-needed guidance to clinicians treating a rare and aggressive form of sarcoma. Dr. Peter Anderson explains.
Boosting Effectiveness of Radiation Against Childhood Cancers
With greater precision made possible through image guidance, radiotherapy combined with new chemotherapeutics means radiation will be desirable instead of feared in childhood cancer therapy.
Introducing Pediatric Hematologist-Oncologist Peter Anderson, MD, PhD
This noted pediatric osteosarcoma expert shares his proudest discovery and a few reflections on patient care as he settles in at Cleveland Clinic Children’s.